The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Cytomegalovirus: pathogen, paradigm, and puzzle
Open accessAbstract
A century of progress Human CMV infection is extremely common.A recent analysis in the United States revealed an overall 50% seroprevalence among adults (1), but rates in some populations are even higher.For example, approximately 90% of Mexican-Americans in the United States are seropositive by age 50, as are 88% of stem cell transplant patients in Italy and 96% of individuals in southern Brazil (1-4).Despite its high worldwide prevalence, CMV infections are generally inapparent, except in newborns and immunocompromised individuals, for whom they can cause life-threatening disease affecting many organ systems.The virus was first detected in newborns during the early 20th century, when multiple reports described large cells in the urine of children with an often fatal systemic infection referred to as cytomegalic inclusion disease (5).The midcentury development of cell culture methods enabled propagation of CMV, but its detection in clinical specimens often required weeks of cultivation.Rapid diagnostic testing by centrifugation-enhanced inoculation combined with detection of CMV antigens in the 1980s was a transforming advance, enabling the diagnosis of CMV to be made in a clinically useful time frame (6).The emergence of effective antivirals in the 1990s was opportune, as CMV-associated disease was increasing in parallel with the AIDS epidemic and use of solid organ transplantation (SOT) and HSC transplantation (HCT).During the past two decades, further advances in diagnosis and treatment have greatly improved our ability to control CMV disease, but the virus still accounts for substantial morbidity, mortality, and cost.Along with these clinical advances, remarkable progress has been made in understanding the molecular biology of CMV.Application of the nucleic acid and protein analytic methods led to an appreciation of the extraordinary complexity of CMV, a point solidified by the landmark report of the first complete sequence of a CMV strain in 1990 (7). Refinements to methods for studying CMV gene function have continued to reveal myriad mechanisms underlying CMV's evolutionary success.However, understanding the pathogenesis of CMV diseases remains an enormous challenge, in large part because the virus only grows in human cells and it differs substantially from even its primate-infecting cousins (8-10).Here we summarize the current understanding of CMV biology and disease.The topic is too broad to cover completely in this for-mat, so the interested reader may wish to consult more comprehensive reviews (11, 12), as well as new reports that are certain to appear in the months and years ahead. CMV replication: insights but limitations from the labHuman CMV is the prototypic member of the β herpesvirus subfamily, which also includes human herpes viruses 6 and 7 and many animal CMVs.Its DNA genome is approximately 230 kb in size, the largest among known human viruses, and consists of unique long (UL) and unique short (US) segments, each of which is flanked by inverted repeats (RL and RS; Figure 1).Most of the approximately 200 genes encode proteins, but some express only noncoding RNAs, including approximately 14 microRNAs (miRNAs; refs.13-15).The central portion of the UL region contains clusters of core genes that have homologs in other herpesviruses, such as DNA polymerase, glycoprotein B (gB), and glycoprotein H (gH), whereas the remainder of the genome contain genes primarily found only in β herpesviruses or unique to human CMV (16, 17).In fact, considerable variation has been detected even among human CMV isolates (18).By convention, CMV genes are named by their position within the genome, although some also have additional descriptive names.For example, UL54 (the 54th gene in the UL region, according to the original report of the CMV, strain AD169, sequence; ref. 7) is the DNA polymerase gene.Propagation of CMV in cell culture has been an essential research tool but has definite limitations, in part because passage in the lab selects for mutants adapted for growth in this unnatural setting (19).As a result, commonly used lab strains have multiple mutations, deletions, and rearrangements (20).For example, the end of the UL region in isolates of the lab strains Towne and AD169 lacks approximately 13 kb of DNA, encoding 19 genes that are present in the Toledo strain (21, 22).Remarkably, inactivating mutations in the RL13 gene are detectable by sequence analyses of the viral genome immediately upon propagation of virus in cell culture (23), which suggests that this gene is necessary for success of the virus in humans but strongly inhibitory to replication in cell culture.The fact that most, if not all, prior laboratory-based studies have used only RL13 mutant viruses reinforces the importance of confirming results of laboratory studies with observations from the clinic.Advances in sequencing technology are sure to improve our understanding of the genetic variation of CMV without confounding artifacts that
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Walter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D., & Riddell, S. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510193331603 · Cited by 1,771
Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infection
Kenneson, A., & Cannon, M. J. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.535 · Cited by 1,720
Infection in Organ-Transplant Recipients
Fishman, J. A., & Rubin, R. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806113382407 · Cited by 1,622
Sylwester, A. W., Mitchell, B. L., Edgar, J. B., Taormina, C., Pelte, C., Ruchti, F., Sleath, P. R., Grabstein, K. H., Hosken, N. A., Kern, F., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050882 · Cited by 1,339
Severe Herpesvirus Infections in an Adolescent without Natural Killer Cells
Biron, C. A., Byron, K. S., & Sullivan, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906293202605 · Cited by 1,269
Dollard, S. C., Grosse, S. D., & Ross, D. S. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.544 · Cited by 1,257
Analysis of the Protein-Coding Content of the Sequence of Human Cytomegalovirus Strain AD169
Chee, M. S., Bankier, A. T., Beck, S., Bohni, R., Brown, C. M., Cerny, R., Horsnell, T., Hutchison, C. A., Kouzarides, T., Martignetti, J. A., et al. (1990) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-74980-3_6 · Cited by 1,252
Paya, C., Humar, A., Dominguez, E., Washburn, K., Blumberg, E., Alexander, B., Freeman, R., Heaton, N., & Pescovitz, M. D. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00382.x · Cited by 880
Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection
Nigro, G., Adler, S. P., La Torre, R., & Best, A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043337 · Cited by 784
Herpesvirus latency confers symbiotic protection from bacterial infection
Barton, E. S., White, D. W., Cathelyn, J. S., Brett-McClellan, K. A., Engle, M., Diamond, M. S., Miller, V. L., & Virgin, H. W. (2007) · Nature · doi:10.1038/nature05762 · Cited by 763
Vaccine Prevention of Maternal Cytomegalovirus Infection
Pass, R. F., Zhang, C., Evans, A., Simpson, T., Andrews, W., Huang, M.-L., Corey, L., Hill, J., Davis, E., Flanigan, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804749 · Cited by 713
Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation
Lowance, D., Neumayer, H.-H., Legendre, C. M., Squifflet, J.-P., Kovarik, J., Brennan, P. J., Norman, D., Mendez, R., Keating, M. R., Coggon, G. L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401903 · Cited by 712
Bate, S. L., Dollard, S. C., & Cannon, M. J. (2010) · Clinical Infectious Diseases · doi:10.1086/652438 · Cited by 681
Boeckh, M., Gooley, T., Myerson, D., Cunningham, T., Schoch, G., & Bowden, R. (1996) · Blood · doi:10.1182/blood.v88.10.4063.bloodjournal88104063 · Cited by 646
Self-citationFunctional profiling of a human cytomegalovirus genome
Dunn, W., Chou, C., Li, H., Hai, R., Patterson, D., Stolc, V., Zhu, H., & Liu, F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2334032100 · Cited by 645
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains
Cha, T. A., Tom, E., Kemble, G. W., Duke, G. M., Mocarski, E. S., & Spaete, R. R. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.78-83.1996 · Cited by 611
Antiviral Drug Resistance of Human Cytomegalovirus
Lurain, N. S., & Chou, S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00009-10 · Cited by 596
Analysis of the complete DNA sequence of murine cytomegalovirus
Rawlinson, W. D., Farrell, H. E., & Barrell, B. G. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8833-8849.1996 · Cited by 591
Reactivation of Genital Herpes Simplex Virus Type 2 Infection in Asymptomatic Seropositive Persons
Wald, A., Zeh, J., Selke, S., Warren, T., Ryncarz, A. J., Ashley, R., Krieger, J. N., & Corey, L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421203 · Cited by 582
Species Interactions in a Parasite Community Drive Infection Risk in a Wildlife Population
Telfer, S., Lambin, X., Birtles, R., Beldomenico, P., Burthe, S., Paterson, S., & Begon, M. (2010) · Science · doi:10.1126/science.1190333 · Cited by 567
Genetic content of wild-type human cytomegalovirus
Dolan, A., Cunningham, C., Hector, R. D., Hassan-Walker, A. F., Lee, L., Addison, C., Dargan, D. J., McGeoch, D. J., Gatherer, D., Emery, V. C., et al. (2004) · Journal of General Virology · doi:10.1099/vir.0.79888-0 · Cited by 557
Topics in herpesvirus genomics and evolution
McGeoch, D. J., Rixon, F. J., & Davison, A. J. (2006) · Virus Research · doi:10.1016/j.virusres.2006.01.002 · Cited by 544
Hahn, G., Revello, M. G., Patrone, M., Percivalle, E., Campanini, G., Sarasini, A., Wagner, M., Gallina, A., Milanesi, G., Koszinowski, U., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.18.10023-10033.2004 · Cited by 467
Vaccines for the 21st Century: A Tool for Decisionmaking
Stratton, K. R., Durch, J. S., & Lawrence, R. S. (2013) · Cited by 444
Feuchtinger, T., Opherk, K., Bethge, W. A., Topp, M. S., Schuster, F. R., Weissinger, E. M., Mohty, M., Or, R., Maschan, M., Schumm, M., et al. (2010) · Blood · doi:10.1182/blood-2010-01-262089 · Cited by 435
Boeckh, M., Nichols, W. G., Papanicolaou, G., Rubin, R., Wingard, J. R., & Zaia, J. (2003) · Biology of Blood and Marrow Transplantation · doi:10.1016/s1083-8791(03)00287-8 · Cited by 431
Self-citationCytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Ljungman, P., Hakki, M., & Boeckh, M. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.11.011 · Cited by 423
Self-citationFunctional map of human cytomegalovirus AD169 defined by global mutational analysis
Yu, D., Silva, M. C., & Shenk, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1635160100 · Cited by 409
Sinzger, C., Digel, M., & Jahn, G. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-77349-8_4 · Cited by 394
A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis
Martin, D. F., Sierra-Madero, J., Walmsley, S., Wolitz, R. A., Macey, K., Georgiou, P., Robinson, C. A., & Stempien, M. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011759 · Cited by 394
Kalil, A. C., Levitsky, J., Lyden, E., Stoner, J., & Freifeld, A. G. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-12-200512200-00005 · Cited by 389
Mitchell, D. A., Xie, W., Schmittling, R., Learn, C., Friedman, A., McLendon, R. E., & Sampson, J. H. (2008) · Neuro-Oncology · doi:10.1215/15228517-2007-035 · Cited by 388
Boppana, S. B. (2010) · JAMA · doi:10.1001/jama.2010.423 · Cited by 383
Lalezari, J. P., Stagg, R. J., Kuppermann, B. D., Holland, G. N., Kramer, F., Ives, D. V., Youle, M., Robinson, M. R., Drew, W. L., & Jaffe, H. S. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-4-199702150-00001 · Cited by 372
Grosse, S. D., Ross, D. S., & Dollard, S. C. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.09.004 · Cited by 364
Human Cytomegalovirus UL131 Open Reading Frame Is Required for Epithelial Cell Tropism
Wang, D., & Shenk, T. E. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10330-10338.2005 · Cited by 334
Ryckman, B. J., Jarvis, M. A., Drummond, D. D., Nelson, J. A., & Johnson, D. C. (2006) · Journal of Virology · doi:10.1128/jvi.80.2.710-722.2006 · Cited by 330
Palestine, A. G., Polis, M. A., De Smet, M. D., Baird, B. F., Falloon, J., Kovacs, J. A., Davey, R. T., Zurlo, J. J., Zunich, K. M., Davis, M., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-665 · Cited by 327
Macagno, A., Bernasconi, N. L., Vanzetta, F., Dander, E., Sarasini, A., Revello, M. G., Gerna, G., Sallusto, F., & Lanzavecchia, A. (2010) · Journal of Virology · doi:10.1128/jvi.01809-09 · Cited by 326
Platelet-derived growth factor-α receptor activation is required for human cytomegalovirus infection
Soroceanu, L., Akhavan, A., & Cobbs, C. S. (2008) · Nature · doi:10.1038/nature07209 · Cited by 297
Passive Immunization During Pregnancy for Congenital Cytomegalovirus Infection
Nigro, G., Adler, S. P., La Torre, R., & Best, A. M. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000201909.22099.cc · Cited by 295
Cytomegalovirus in transplantation – challenging the status quo
Fishman, J. A., Emery, V., Freeman, R., Pascual, M., Rostaing, L., Schlitt, H. J., Sgarabotto, D., Torre‐Cisneros, J., & Uknis, M. E. (2007) · Clinical Transplantation · doi:10.1111/j.1399-0012.2006.00618.x · Cited by 289
Oliver, S. E., Cloud, G. A., Sánchez, P. J., Demmler, G. J., Dankner, W., Shelton, M., Jacobs, R. F., Vaudry, W., Pass, R. F., Soong, S.-J., et al. (2009) · Journal of Clinical Virology · doi:10.1016/j.jcv.2009.08.012 · Cited by 277
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
Hodson, E. M., Ladhani, M., Webster, A. C., Strippoli, G. F., & Craig, J. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003774.pub4 · Cited by 268
Evasion of CD8 + T Cells Is Critical for Superinfection by Cytomegalovirus
Hansen, S. G., Powers, C. J., Richards, R., Ventura, A. B., Ford, J. C., Siess, D., Axthelm, M. K., Nelson, J. A., Jarvis, M. A., Picker, L. J., et al. (2010) · Science · doi:10.1126/science.1185350 · Cited by 264
Palmer, S. M., Limaye, A. P., Banks, M., Gallup, D., Chapman, J., Lawrence, E. C., Dunitz, J., Milstone, A., Reynolds, J., Yung, G. L., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-12-201006150-00003 · Cited by 259
Prevention of child-to-mother transmission of cytomegalovirus among pregnant women
Adler, S. P., Finney, J. W., Manganello, A. M., & Best, A. M. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.05.041 · Cited by 258
Stanton, R. J., Baluchova, K., Dargan, D. J., Cunningham, C., Sheehy, O., Seirafian, S., McSharry, B. P., Neale, M. L., Davies, J. A., Tomasec, P., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42955 · Cited by 256
Winston, D. J., Young, J.-A. H., Pullarkat, V., Papanicolaou, G. A., Vij, R., Vance, E., Alangaden, G. J., Chemaly, R. F., Petersen, F., Chao, N., et al. (2008) · Blood · doi:10.1182/blood-2007-11-121558 · Cited by 245
Self-citationDetection of human cytomegalovirus in different histological types of gliomas
Scheurer, M. E., Bondy, M. L., Aldape, K. D., Albrecht, T., & El-Zein, R. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0359-1 · Cited by 244
In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246
Lischka, P., Hewlett, G., Wunberg, T., Baumeister, J., Paulsen, D., Goldner, T., Ruebsamen-Schaeff, H., & Zimmermann, H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01596-09 · Cited by 240
Modulation of natural killer cells by human cytomegalovirus
Wilkinson, G. W. G., Tomasec, P., Stanton, R. J., Armstrong, M., Prod’homme, V., Aicheler, R., McSharry, B. P., Rickards, C. R., Cochrane, D., Llewellyn-Lacey, S., et al. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.10.027 · Cited by 239
Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products
Nichols, W. G., Price, T. H., Gooley, T., Corey, L., & Boeckh, M. (2003) · Blood · doi:10.1182/blood-2002-10-3143 · Cited by 232
Self-citation(2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01327-2 · Cited by 222
Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients
Ljungman, P. (2001) · Blood · doi:10.1182/blood.v97.2.388 · Cited by 220
Kalil, A. C., & Florescu, D. F. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a3aa43 · Cited by 208
Cytomegalovirus Reinfections in Healthy Seroimmune Women
Ross, S. A., Arora, N., Novak, Z., Fowler, K. B., Britt, W. J., & Boppana, S. B. (2010) · The Journal of Infectious Diseases · doi:10.1086/649903 · Cited by 204
Human Cytomegalovirus Induces the Interferon Response via the DNA Sensor ZBP1
DeFilippis, V. R., Alvarado, D., Sali, T., Rothenburg, S., & Früh, K. (2010) · Journal of Virology · doi:10.1128/jvi.01748-09 · Cited by 203
Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture
Dargan, D. J., Douglas, E., Cunningham, C., Jamieson, F., Stanton, R. J., Baluchova, K., McSharry, B. P., Tomasec, P., Emery, V. C., Percivalle, E., et al. (2010) · Journal of General Virology · doi:10.1099/vir.0.018994-0 · Cited by 193
Cytomegalovirus Immune Evasion
Powers, C., DeFilippis, V., Malouli, D., & Früh, K. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-77349-8_19 · Cited by 185
Aspects of Human Cytomegalovirus Latency and Reactivation
Reeves, M., & Sinclair, J. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-77349-8_17 · Cited by 184
Gerna, G., Sarasini, A., Patrone, M., Percivalle, E., Fiorina, L., Campanini, G., Gallina, A., Baldanti, F., & Revello, M. G. (2008) · Journal of General Virology · doi:10.1099/vir.0.83523-0 · Cited by 179
Prichard, M. N., Penfold, M. E. T., Duke, G. M., Spaete, R. R., & Kemble, G. W. (2001) · Reviews in Medical Virology · doi:10.1002/rmv.315 · Cited by 176
Complete Sequence and Genomic Analysis of Rhesus Cytomegalovirus
Hansen, S. G., Strelow, L. I., Franchi, D. C., Anders, D. G., & Wong, S. W. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6620-6636.2003 · Cited by 174
Prevention of Child-to-Mother Transmission of Cytomegalovirus Among Pregnant Women
(2006) · Yearbook of Pediatrics · doi:10.1016/s0084-3954(07)70166-5 · Cited by 172
Kurz, S., Steffens, H. P., Mayer, A., Harris, J. R., & Reddehase, M. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2980-2987.1997 · Cited by 164
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Ljungman, P., Hakki, M., & Boeckh, M. (2010) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.01.008 · Cited by 160
Self-citationRaanani, P., Gafter-Gvili, A., Paul, M., Ben-Bassat, I., Leibovici, L., & Shpilberg, O. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.8450 · Cited by 160
Late-Onset Cytomegalovirus Disease in Liver Transplant Recipients Despite Antiviral Prophylaxis1
Limaye, A. P., Bakthavatsalam, R., Kim, H. W., Kuhr, C. S., Halldorson, J. B., Healey, P. J., & Boeckh, M. (2004) · Transplantation · doi:10.1097/01.tp.0000145989.22373.03 · Cited by 158
Self-citationNachmani, D., Lankry, D., Wolf, D. G., & Mandelboim, O. (2010) · Nature Immunology · doi:10.1038/ni.1916 · Cited by 158
Transmission of cytomegalovirus via breast milk to the prematurely born infant: a systematic review
Kurath, S., Halwachs‐Baumann, G., Müller, W., & Resch, B. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03140.x · Cited by 157
Virus-Encoded Homologs of Cellular Interleukin-10 and Their Control of Host Immune Function
Slobedman, B., Barry, P. A., Spencer, J. V., Avdic, S., & Abendroth, A. (2009) · Journal of Virology · doi:10.1128/jvi.01098-09 · Cited by 155
Longitudinal Study of the Ocular Complications of AIDS
Jabs, D. A., Natta, M. L. V., Holbrook, J. T., Kempen, J. H., Meinert, C. L., & Davis, M. D. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.11.008 · Cited by 144
Waldman, W. J., Knight, D. A., Lurain, N. S., et al. (1999) · Transplantation · doi:10.1097/00007890-199909270-00014 · Cited by 143
Meier, J., Lienicke, U., Tschirch, E., Krüger, D. H., Wauer, R. R., & Prösch, S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.3.1318-1324.2005 · Cited by 135
Alter, E. L. A. W., Hilip, P., Reenberg, D. G., Ilbert, M. A. J. G., Inch, R. O. J. F., Atanabe, S. W., Onnall, E. D., Homas, T., & Iddell, S. T. R. R. (2011) · Cited by 117
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
Hodson, E. M., Craig, J. C., Strippoli, G. F., & Webster, A. C. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003774.pub3 · Cited by 117
High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169
Bradley, A. J., Lurain, N. S., Ghazal, P., Trivedi, U. H., Cunningham, C., Baluchova, K., Gatherer, D., Wilkinson, G. W. G., Dargan, D. J., & Davison, A. J. (2009) · Journal of General Virology · doi:10.1099/vir.0.013250-0 · Cited by 115
Lilleri, D., Fornara, C., Chiesa, A., Caldera, D., Alessandrino, E. P., & Gerna, G. (2008) · Haematologica · doi:10.3324/haematol.11912 · Cited by 106
Manley, T. J., Luy, L., Jones, T. R., Boeckh, M., Mutimer, H. P., & Riddell, S. R. (2004) · Blood · doi:10.1182/blood-2003-06-1937 · Cited by 106
Self-citationCMV in critically ill patients: pathogen or bystander?
Limaye, A. P., & Boeckh, M. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.664 · Cited by 103
Self-citationHodson, E. M., Jones, C., Strippoli, G. F., Webster, A. C., & Craig, J. C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005129.pub2 · Cited by 99
Longitudinal Study of the Ocular Complications of AIDS
Jabs, D. A., Natta, M. L. V., Holbrook, J. T., Kempen, J. H., Meinert, C. L., & Davis, M. D. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.07.065 · Cited by 94
Shenk, T. E., & Stinski, M. F. (2008) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-77349-8 · Cited by 91
Cytomegalovirus Vaccine Development
Schleiss, M. R. (2008) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-77349-8_20 · Cited by 88
Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy
O'Brien, S. M., Ravandi, F., Riehl, T., Wierda, W. G., Huang, X., Tarrand, J. J., O’Neal, B., Kantarjian, H. M., & Keating, M. J. (2007) · Blood · doi:10.1182/blood-2007-03-080010 · Cited by 88
Immunosenescence and Cytomegalovirus: where do we stand after a decade?
Pawelec, G., Akbar, A. N., Beverley, P. C. L., Caruso, C., Derhovanessian, E., Fülöp, T., Griffiths, P. D., Grubeck‐Loebenstein, B., Hamprecht, K., Jahn, G., et al. (2010) · Immunity & Ageing · doi:10.1186/1742-4933-7-13 · Cited by 86
Noda, S., Aguirre, S. A., BitMansour, A., Brown, J. W., Sparer, T. E., Huang, J., & Mocarski, E. S. (2005) · Blood · doi:10.1182/blood-2005-05-1833 · Cited by 81
Multifaceted Evasion of the Interferon Response by Cytomegalovirus
Marshall, E. E., & Geballe, A. P. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0064 · Cited by 80
Self-citationThe role of cytomegalovirus in angiogenesis
Caposio, P., Orloff, S. L., & Streblow, D. N. (2010) · Virus Research · doi:10.1016/j.virusres.2010.09.011 · Cited by 80
Adoptive transfer of virus-specific and tumor-specific T cell immunity
Berger, C., Turtle, C. J., Jensen, M. C., & Riddell, S. R. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.02.010 · Cited by 77
Virus Entry and Innate Immune Activation
Isaacson, M. K., Juckem, L., & Compton, T. (2008) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-77349-8_5 · Cited by 74
Pollack, M., Heugel, J., Xie, H., Leisenring, W. M., Storek, J., Young, J. H., Kukreja, M. K., Gress, R. E., Tomblyn, M. R., & Boeckh, M. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.07.026 · Cited by 72
Self-citationControl of Apoptosis by Human Cytomegalovirus
McCormick, A. L. (2008) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-77349-8_16 · Cited by 70
Totonchy, J. E., Melnychuk, R., Smith, P. P., Powell, J. D., Hall, L., DeFilippis, V. R., Früh, K., Smit, M. J., Schlaepfer, D. D., Nelson, J. A., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000304 · Cited by 69
Chapter 5 Rhesus Cytomegalovirus
Yue, Y., & Barry, P. A. (2008) · Advances in virus research · doi:10.1016/s0065-3527(08)00405-3 · Cited by 61
Lurain, N. S., Fox-Canale, A. M., Lichy, H. M., Bhorade, S. M., Ware, C. F., Huang, D. D., Kwan, S., Garrity, E. R., & Chou, S. (2006) · Virology Journal · doi:10.1186/1743-422x-3-4 · Cited by 58
Moss, P. A. H. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.07.001 · Cited by 53
Human Cytomegalovirus 5-Kilobase Immediate-Early RNA Is a Stable Intron
Kulesza, C. A., & Shenk, T. E. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13182-13189.2004 · Cited by 48
Cmv1 and Natural Killer Cell Responses to Murine Cytomegalovirus Infection
Scalzo, A. A., & Yokoyama, W. M. (2008) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-75203-5_5 · Cited by 42
Rhesus Cytomegalovirus Particles Prevent Activation of Interferon Regulatory Factor 3
DeFilippis, V. R., & Früh, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6419-6431.2005 · Cited by 35
Human Cytomegalovirus microRNAs
Rider, P. J. F., Dunn, W., Yang, E., & Liu, F. (2008) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-77349-8_2 · Cited by 21
Immunotherapy and Vaccination After Transplant: The Present, the Future
Emery, V. C., Einsele, H., Atabani, S. F., & Haque, T. (2010) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.01.004 · Cited by 5
Cited by
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
The pathogenesis of human cytomegalovirus
Griffiths, P., Baraniak, I., & Reeves, M. (2015) · The Journal of Pathology · doi:10.1002/path.4437 · Cited by 592
Asymmetric organocatalysis: an enabling technology for medicinal chemistry
Han, B., He, X.-H., Liu, Y.-Q., He, G., Peng, C., & Li, J.-L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00196a · Cited by 402
Applications of gold nanoparticles in virus detection
Draz, M. S., & Shafiee, H. (2018) · Theranostics · doi:10.7150/thno.23856 · Cited by 342
Cytomegalovirus Infections in Solid Organ Transplantation: A Review
Ramanan, P., & Razonable, R. R. (2013) · Infection & Chemotherapy · doi:10.3947/ic.2013.45.3.260 · Cited by 339
Metadata
- Authors
- Boeckh, M., & Geballe, A. P.
- Venue
- Journal of Clinical Investigation
- Published
- 2011-05-02
- Volume
- 121
- Issue
- 5
- Pages
- 1673-1680
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1991308016
- Cited by
- 357
- References
- 104
- FWCI
- 17.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.